Related Experiment Video
Updated: Jul 4, 2026
08:04
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
Poor prognosis osteosarcoma: new therapeutic approach
F Fagioli1, E Biasin, O M Mereuta
1Stem Cell Transplantation and Cellular Therapy Unit, Regina Margherita Children's Hospital, Turin, Italy. franca.fagioli@unito.it
Bone Marrow Transplantation
|July 24, 2008
Summary
Despite improved outcomes for localized osteosarcoma, many patients relapse. This study explores novel T-cytotoxic lymphocyte therapies to improve survival for recurrent or metastatic osteosarcoma.
Area of Science:
- Oncology
- Immunotherapy
Background:
- Localized osteosarcoma prognosis has improved over 30 years.
- However, 30-40% of patients experience relapse, often within 3 years.
- Recurrent or metastatic disease carries a poor prognosis.
Purpose of the Study:
- To investigate novel therapeutic strategies for osteosarcoma.
- To explore the potential of T-cytotoxic lymphocytes in treating osteosarcoma.
Main Methods:
- Review of current treatment outcomes for osteosarcoma.
- Exploration of biological agents like IL-2 and allogeneic SCT.
- An ongoing study investigating specific T-cytotoxic lymphocytes.
Main Results:
- Chemotherapy dose escalation shows limited survival benefit.
- Targeted therapies have yielded poor results.
- Immunomodulatory agents and SCT show promise but require further validation.
Conclusions:
- Novel approaches are needed to improve osteosarcoma patient survival.
- T-cytotoxic lymphocyte therapy presents a potential avenue for future treatment.
- Further research is crucial to confirm the efficacy of emerging immunotherapies.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...